{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:52:55Z","timestamp":1794959575392,"version":"4.9.1"},"reference-count":138,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The congenital dyserythropoietic anemias (CDA) are hereditary disorders characterized by ineffective erythropoiesis. This review evaluates newly developed CDA disease models, the latest advances in understanding the pathogenesis of the CDAs, and recently identified CDA genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Mice exhibiting features of CDAI were recently generated, demonstrating that Codanin-1 (encoded by <jats:italic toggle=\"yes\">Cdan1<\/jats:italic>) is essential for primitive erythropoiesis. Additionally, Codanin-1 was found to physically interact with CDIN1, suggesting that mutations in <jats:italic toggle=\"yes\">CDAN1<\/jats:italic> and <jats:italic toggle=\"yes\">CDIN1<\/jats:italic> result in CDAI via a common mechanism. Recent advances in CDAII (which results from <jats:italic toggle=\"yes\">SEC23B<\/jats:italic> mutations) have also been made. SEC23B was found to functionally overlap with its paralogous protein, SEC23A, likely explaining the absence of CDAII in SEC23B-deficient mice. In contrast, mice with erythroid-specific deletion of 3 or 4 of the <jats:italic toggle=\"yes\">Sec23<\/jats:italic> alleles exhibited features of CDAII. Increased SEC23A expression rescued the CDAII erythroid defect, suggesting a novel therapeutic strategy for the disease. Additional recent advances included the identification of new CDA genes, <jats:italic toggle=\"yes\">RACGAP1<\/jats:italic> and <jats:italic toggle=\"yes\">VPS4A,<\/jats:italic> in CDAIII and a syndromic CDA type, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Establishing cellular and animal models of CDA is expected to result in improved understanding of the pathogenesis of these disorders, which may ultimately lead to the development of new therapies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/moh.0000000000000697","type":"journal-article","created":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T18:00:29Z","timestamp":1640541629000},"page":"126-136","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["The congenital dyserythropoieitic anemias: genetics and pathophysiology"],"prefix":"10.1097","volume":"29","author":[{"given":"Richard","family":"King","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Michigan"},{"name":"University of Michigan Rogel Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Department of Molecular, Cellular and Developmental Biology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Khoriaty","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan"},{"name":"University of Michigan Rogel Cancer Center"},{"name":"Cellular and Molecular Biology Program"},{"name":"Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0609.2010.01440.x","article-title":"Frequency of congenital dyserythropoietic anemias in Europe","volume":"85","author":"Heimpel","year":"2010","journal-title":"Eur J Hematol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-90-481-9485-8_22","article-title":"Epidemiology of rare anaemias in Europe","volume":"686","author":"Gulbis","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/jmedgenet-2020-106880","article-title":"Genetic and functional insights into CDA- I prevalence and pathogenesis","volume":"58","author":"Olijnik","year":"2021","journal-title":"J Med Genet"},{"key":"R4-20250729","article-title":"The hereditary dyserythropoietic anemias","author":"lolascon","year":"2021","journal-title":"Williams Hematology"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood.2019000948","article-title":"Congenital dyserythropoietic anemias","volume":"136","author":"lolascon","year":"2020","journal-title":"Blood"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/bjh.15817","article-title":"The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I","volume":"185","author":"Roy","year":"2019","journal-title":"Br J Haematol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1586\/17474086.2016.1131608","article-title":"Diagnosis and management of congenital dyserythropoietic anemias","volume":"9","author":"Gambale","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"108336","DOI":"10.1016\/j.mrrev.2020.108336","article-title":"Severe anemia caused by dominant mutations in Kruppel-like factor 1 (KLF1)","volume":"786","author":"Kulczynska-Figurny","year":"2020","journal-title":"Mutat Res Rev Mutat Res"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hoc.2019.01.002","article-title":"Rare hereditary hemolytic anemias: diagnostic approach and considerations in management","volume":"33","author":"Risinger","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ejh.13112","article-title":"Clinical and genetic features of congenital dyserythropoietic anemia (CDA)","volume":"101","author":"Moreno-Carralero","year":"2018","journal-title":"Eur J Hematol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/088800101753328510","article-title":"Lethal hydrops fetalis due to congenital dyserythropoietic anemia in a newborn: association of a new skeletal abnormality","volume":"18","author":"Tekinalp","year":"2001","journal-title":"Pediatr Hematol Oncol"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/blood-2001-12-0351","article-title":"Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation","volume":"100","author":"Remacha","year":"2002","journal-title":"Blood"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2013-05-468223","article-title":"Congenital dyserythropoietic anemias: molecular insights and diagnostic approach","volume":"122","author":"lolascon","year":"2013","journal-title":"Blood"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ng.405","article-title":"Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II","volume":"41","author":"Schwarz","year":"2009","journal-title":"Nat Genet"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2003-02-0613","article-title":"Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation","volume":"102","author":"Heimpel","year":"2003","journal-title":"Blood"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood.V98.4.1258","article-title":"Natural history of congenital dyserythropoietic anemia type II","volume":"98","author":"lolascon","year":"2001","journal-title":"Blood"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ejh.12778","article-title":"Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I","volume":"98","author":"Shalev","year":"2017","journal-title":"Eur J Hematol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3324\/haematol.2009.014563","article-title":"The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells","volume":"95","author":"Heimpel","year":"2010","journal-title":"Haematologica"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0268-960X(98)90016-9","article-title":"Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data","volume":"12","author":"Wickramasinghe","year":"1998","journal-title":"Blood Rev"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood-2005-01-0421","article-title":"Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation","volume":"107","author":"Heimpel","year":"2006","journal-title":"Blood"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"102534","DOI":"10.1016\/j.bcmd.2020.102534","article-title":"CDAR consortium. Congenital dyserythropoietic anemia type I: first report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)","volume":"87","author":"Niss","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3476(00)90025-8","article-title":"Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension of the newborn","volume":"136","author":"Shalev","year":"2000","journal-title":"J Pediatr"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0609.2007.01004.x","article-title":"Congenital dyserythropoietic anaemia, type I, in a Caucasian patient with retinal angioid streaks (homozygous Arg1042Trp mutation in codanin-1)","volume":"80","author":"Tamary","year":"2008","journal-title":"Eur J Hematol"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2020.05.092","article-title":"Prevalence of left ventricular hypertrabeculation\/noncompaction among patients with congenital dyserythropoietic anemia Type 1 (CDA1)","volume":"317","author":"Abramovich-Yoffe","year":"2020","journal-title":"Int J Cardiol"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/344781","article-title":"Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1","volume":"71","author":"Dgany","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3324\/haematol.2013.089490","article-title":"Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I","volume":"98","author":"Babbs","year":"2013","journal-title":"Haematologica"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1182\/blood-2010-09-308478","article-title":"Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1 {alpha} localization in erythroblasts","volume":"117","author":"Renella","year":"2011","journal-title":"Blood"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3324\/haematol.2008.003327","article-title":"Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated","volume":"94","author":"Noy-Lotan","year":"2009","journal-title":"Haematologica"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/emboj.2012.55","article-title":"Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply","volume":"31","author":"Ask","year":"2012","journal-title":"EMBO J"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12860-020-00258-1","article-title":"Characterization of the interactions between Codanin-1 and C150rf41, two proteins implicated in congenital dyserythropoietic anemia type I disease","volume":"21","author":"Swickley","year":"2020","journal-title":"BMC Mol Cell Biol"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.3324\/haematol.2020.260158","article-title":"Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities","volume":"106","author":"Scott","year":"2021","journal-title":"Haematologica"},{"key":"R32-20250729","first-page":"1","article-title":"Robust CRISPR\/Cas9 genome editing of the HUDEP-2 erythroid precursor line using plasmids and single-stranded oligonucleotide donors","author":"Moir-Meyer","year":"2018","journal-title":"Methods Protoc"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"685242","DOI":"10.3389\/fphys.2021.685242","article-title":"Cdan1 is essential for primitive erythropoiesis","volume":"12","author":"Noy-Lotan","year":"2021","journal-title":"Front Physiol"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jcp.39.8.881","article-title":"Studies of erythroblast function in congenital dyserythropoietic anaemia, type I: evidence of impaired DNA, RNA, and protein synthesis and unbalanced globin chain synthesis in ultrastructurally abnormal cells","volume":"39","author":"Wickramasinghe","year":"1986","journal-title":"J Clin Pathol"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/blood.V87.5.1763.1763","article-title":"Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I","volume":"87","author":"Tamary","year":"1996","journal-title":"Blood"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1042\/BCJ20190944","article-title":"A complex comprising C15ORF41 and Codanin-1: the products of two genes mutated in congenital dyserythropoietic anaemia type I (CDA-I)","volume":"477","author":"Shroff","year":"2020","journal-title":"Biochem J"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2141.1995.tb08442.x","article-title":"Alpha-interferon therapy for congenital dyserythropoiesis type I","volume":"89","author":"Lavabre-Bertrand","year":"1995","journal-title":"Br J Haematol"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1365-2141.2000.02168.x","article-title":"Severe congenital dyserythropoietic anaemia type I: prenatal management, transfusion support and alpha-interferon therapy","volume":"110","author":"Parez","year":"2000","journal-title":"Br J Haematol"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0609.2004.00310.x","article-title":"Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I","volume":"73","author":"Lavabre-Bertrand","year":"2004","journal-title":"Eur J Hematol"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/08880010590907221","article-title":"Interferon therapy in congenital dyserythropoietic anemia type l\/ll","volume":"22","author":"Marwaha","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"e26866","DOI":"10.1002\/pbc.26866","article-title":"Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a","volume":"65","author":"Rathe","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/ejh.13428","article-title":"Treatment of transfusion-dependent congenital dyserythropoietic anemia type I patients with pegylated interferon alpha-2a","volume":"105","author":"Abu-Quider","year":"2020","journal-title":"Eur J Hematol"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bmt.1703526","article-title":"Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogeneic stem cell transplantation","volume":"29","author":"Ayas","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.3324\/haematol.2018.206623","article-title":"Stem cell transplantation for congenital dyserythropoietic anemia: an analysis from the European Society for Blood and Marrow Transplantation","volume":"104","author":"Miano","year":"2019","journal-title":"Haematologica"},{"key":"R45-20250729","first-page":"241","article-title":"Hematopoietic stem cell transplantation in children with genetic defects","volume":"46","author":"Nair","year":"2009","journal-title":"Indian Pediatr"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2012-01-292086","article-title":"The COPII pathway and hematologic disease","volume":"120","author":"Khoriaty","year":"2012","journal-title":"Blood"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1182\/blood.V87.10.4433.bloodjournal87104433","article-title":"The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum","volume":"87","author":"Alloisio","year":"1996","journal-title":"Blood"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.1982.tb02820.x","article-title":"Decreased glycosylation of band 3 and band 4.5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II","volume":"51","author":"Scartezzini","year":"1982","journal-title":"Br J Haematol"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.tcb.2008.04.006","article-title":"Coordination of COPII vesicle trafficking by Sec23","volume":"18","author":"Fromme","year":"2008","journal-title":"Trends Cell Biol"},{"issue":"(6B)","key":"R50-20250729","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1101\/gr.978703","article-title":"RIKEN GER Group, GSL Members. Mouse proteome analysis","volume":"13","author":"Kanapin","year":"2003","journal-title":"Genome Res"},{"key":"R51-20250729","doi-asserted-by":"crossref","first-page":"eabj5293","DOI":"10.1126\/sciadv.abj5293","article-title":"SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II","volume":"7","author":"King","year":"2021","journal-title":"Sci Adv"},{"key":"R52-20250729","doi-asserted-by":"crossref","first-page":"E2001","DOI":"10.1073\/pnas.1209207109","article-title":"SEC23B is required for the maintenance of murine professional secretory tissues","volume":"109","author":"Tao","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R53-20250729","doi-asserted-by":"crossref","first-page":"27802","DOI":"10.1038\/srep27802","article-title":"Pancreatic SEC23B deficiency is sufficient to explain the perinatal lethality of germline SEC23B deficiency in mice","volume":"6","author":"Khoriaty","year":"2016","journal-title":"Sci Rep"},{"key":"R54-20250729","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1091\/mbc.e17-01-0001","article-title":"SEC23B is required for pancreatic acinar cell function in adult mice","volume":"28","author":"Khoriaty","year":"2017","journal-title":"Mol Biol Cell"},{"key":"R55-20250729","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1128\/MCB.00287-14","article-title":"Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B","volume":"34","author":"Khoriaty","year":"2014","journal-title":"Mol Cell Biol"},{"key":"R56-20250729","doi-asserted-by":"crossref","first-page":"E7748","DOI":"10.1073\/pnas.1805784115","article-title":"Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo","volume":"115","author":"Khoriaty","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"R57-20250729","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.celrep.2016.06.085","article-title":"Comprehensive proteomic analysis of human erythropoiesis","volume":"16","author":"Gautier","year":"2016","journal-title":"Cell Rep"},{"key":"R58-20250729","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/bloodadvances.2020001652","article-title":"Comprehensive proteomic analysis of murine terminal erythroid differentiation","volume":"4","author":"Gautier","year":"2020","journal-title":"Blood Adv"},{"key":"R59-20250729","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcmd.2013.02.003","article-title":"Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II","volume":"51","author":"Russo","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"R60-20250729","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.bmt.1702764","article-title":"Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II)","volume":"27","author":"lolascon","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R61-20250729","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1182\/blood-2002-02-0651","article-title":"Allogeneic bone marrow transplantation: cure for familial Mediterranean fever","volume":"100","author":"Milledge","year":"2002","journal-title":"Blood"},{"key":"R62-20250729","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcmd.2010.03.005","article-title":"CDAII presenting as hydrops foetalis: molecular characterization of two cases","volume":"45","author":"Fermo","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"R63-20250729","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1111\/j.1399-3046.2010.01414.x","article-title":"Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload","volume":"16","author":"Buchbinder","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R64-20250729","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/pbc.24786","article-title":"Successful treatment of an infant with CDA type II by intrauterine transfusions and postnatal stem cell transplantation","volume":"61","author":"Braun","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R65-20250729","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.1111\/petr.12254","article-title":"Successful hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia type II","volume":"18","author":"Unal","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R66-20250729","first-page":"792485","article-title":"Successful allogeneic hematopoietic stem cell transplantation of a patient suffering from type II congenital dyserythropoietic anemia: a rare case report from Western India","volume":"2015","author":"Modi","year":"2015","journal-title":"Case Rep Hematol"},{"key":"R67-20250729","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1097\/MPH.0000000000001612","article-title":"Hematopoietic stem cell transplantation in congenital dyserythropetic anemia type II: a case report and review of the literature","volume":"42","author":"Uygun","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"R68-20250729","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.3324\/haematol.2018.206623","article-title":"Stem cell transplantation for congenital dyserythropoietic anemia: an analysis from the European Society for Blood and Marrow Transplantation","volume":"104","author":"Maurizio","year":"2019","journal-title":"Haematologica"},{"key":"R69-20250729","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa1908892","article-title":"Luspatercept in patients with lower-risk myelodysplastic syndromes","volume":"382","author":"Fenaux","year":"2020","journal-title":"New Engl J Med"},{"key":"R70-20250729","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia","volume":"382","author":"Cappellini","year":"2020","journal-title":"New Engl JMed"},{"key":"R71-20250729","article-title":"RAP-011 rescues the disease phenotype in a cellular model of congenital dyserythropoietic anemia type II by inhibiting the SMAD2-3 pathway","volume":"21","author":"De Rosa","year":"2020","journal-title":"Int JMol Sci"},{"key":"R72-20250729","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ncb1962","article-title":"Regulation of endoplasmic reticulum stress response by a BBF2H7-mediated Sec23a pathway is essential for chondrogenesis","volume":"11","author":"Saito","year":"2009","journal-title":"Nat Cell Biol"},{"key":"R73-20250729","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1083\/jcb.201609100","article-title":"UPR transducer BBF2H7 allows export of type II collagen in a cargo- and developmental stage-specific manner","volume":"216","author":"Ishikawa","year":"2017","journal-title":"J Cell Biol"},{"key":"R74-20250729","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/bjh.15189","article-title":"Transduction with BBF2H7\/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII","volume":"184","author":"Pellegrin","year":"2019","journal-title":"Br J Haematol"},{"key":"R75-20250729","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood.V6.12.1274.1274","article-title":"Familial erythroid multinuclearity","volume":"6","author":"Wolff","year":"1951","journal-title":"Blood"},{"key":"R76-20250729","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2141.1972.tb03463.x","article-title":"Congenital dyserythropoietic anaemia, type III","volume":"23","author":"Goudsmit","year":"1972","journal-title":"Br J Haematol"},{"key":"R77-20250729","first-page":"545","article-title":"Congenital dyserythropoiesis with erythroblastic polyploidy. Report of a variety found in Argentinian Mesopotamia","volume":"26","author":"Accame","year":"1981","journal-title":"Sangre"},{"key":"R78-20250729","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000207119","article-title":"Congenital dyserythropoietic anaemias: splenectomy as a mode of therapy","volume":"66","author":"Choudhry","year":"1981","journal-title":"Acta Haematol"},{"key":"R79-20250729","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/jcp.35.10.1103","article-title":"A new case of congenital dyserythropoietic anaemia, type III: studies of the cell cycle distribution and ultrastructure of erythroblasts and of nucleic acid synthesis in marrow cells","volume":"35","author":"Wickramasinghe","year":"1982","journal-title":"J Clin Pathol"},{"key":"R80-20250729","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/bmt.2017.17","article-title":"Nonmyeloablative allogeneic stem cell transplant with posttransplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia","volume":"52","author":"Oh","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"R81-20250729","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00277-020-04319-5","article-title":"Congenital dyserythropoietic anemia types lb, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene","volume":"100","author":"M\u00e9ndez","year":"2021","journal-title":"Ann Hematol"},{"key":"R82-20250729","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000040712","article-title":"A patient with congenital dyserythropoietic anaemia type III presenting with stillbirths","volume":"99","author":"Jijina","year":"1998","journal-title":"Acta Haematol"},{"key":"R83-20250729","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/1096-8652(200008)64:4<314::AID-AJH14>3.0.CO;2-O","article-title":"Congenital dyserythropoietic anemia type III associated with congenital atrioseptal defect has led to severe cardiac problems in a 32-year-old patient","volume":"64","author":"R\u00f6hrig","year":"2000","journal-title":"Am J Hematol"},{"key":"R84-20250729","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajh.10086","article-title":"New sporadic case of congenital dyserythropoietic anemia type III in an aged woman: detailed description of ultrastructural findings","volume":"70","author":"Sigler","year":"2002","journal-title":"Am J Hematol"},{"key":"R85-20250729","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00277-015-2379-y","article-title":"Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III","volume":"94","author":"Carreno-Tarragona","year":"2015","journal-title":"Ann Hematol"},{"key":"R86-20250729","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ajmg.a.38012","article-title":"Distal limb anomalies in patients with congenital dyserythropoietic anemia","volume":"173","author":"Amir","year":"2017","journal-title":"American J Med Genet Part A"},{"key":"R87-20250729","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood.V19.3.296.296","article-title":"Hereditary benign erythroreticulosis","volume":"19","author":"Bergstrom","year":"1962","journal-title":"Blood"},{"key":"R88-20250729","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1365-2141.1997.2883105.x","article-title":"Angioid streaks are part of a familial syndrome of dyserythropoietic anaemia (CDA III)","volume":"98","author":"Sandstrom","year":"1997","journal-title":"Br J Haematol"},{"key":"R89-20250729","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.1994.tb01283.x","article-title":"Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III","volume":"52","author":"Sandstrom","year":"1994","journal-title":"Eur J Hematol"},{"key":"R90-20250729","first-page":"753","article-title":"Congenital dyserythropoietic anemia type III","volume":"85","author":"Sandstrom","year":"2000","journal-title":"Haematologica"},{"key":"R91-20250729","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1182\/blood-2012-10-461392","article-title":"Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23","volume":"121","author":"Liljeholm","year":"2013","journal-title":"Blood"},{"key":"R92-20250729","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.0.CO;2-C","article-title":"Arf proteins bind to mitotic kinesin-like protein 1 (MKLP1) in a GTP-dependent fashion","volume":"44","author":"Boman","year":"1999","journal-title":"Cell Motil Cytoskeleton"},{"key":"R93-20250729","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1038\/emboj.2012.139","article-title":"ARF6 GTPase protects the postmitotic midbody from 14-3-3-mediated disintegration","volume":"31","author":"Joseph","year":"2012","journal-title":"EMBO J"},{"key":"R94-20250729","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcdb.2016.03.006","article-title":"Centralspindlin in Rappaport's cleavage signaling","volume":"53","author":"Mishima","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R95-20250729","doi-asserted-by":"crossref","first-page":"102483","DOI":"10.1016\/j.bcmd.2020.102483","article-title":"Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III","volume":"85","author":"Vikberg","year":"2020","journal-title":"Blood Cells Mol Dis"},{"key":"R96-20250729","article-title":"RACGAP1 variants in a sporadic case of CDA III implicates the dysfunction of centralspindlin as the basis of the disease","author":"Wontakal","year":"2021","journal-title":"Blood"},{"issue":"(Suppl 1)","key":"R97-20250729","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2021-150097","article-title":"Autosomal recessive congenital dyserythropoietic anemia type III is caused by mutations in the centralspindlin RACGAP1 component","volume":"138","author":"Romero-Cortadellas","year":"2021","journal-title":"Blood"},{"key":"R98-20250729","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1534-5807(01)00110-1","article-title":"Central spindle assembly and cytokinesis require a kinesin-like protein\/RhoGAP complex with microtubule bundling activity","volume":"2","author":"Mishima","year":"2002","journal-title":"Dev Cell"},{"key":"R99-20250729","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1097\/MPH.0000000000001056","article-title":"KLF1 E325K-associated congenital dyserythropoietic anemia type IV: insights into the variable clinical severity","volume":"40","author":"Ravindranath","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"R100-20250729","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2010.10.010","article-title":"A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia","volume":"87","author":"Arnaud","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R101-20250729","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ccr3.825","article-title":"A case of congenital dyserythropoietic anemia type IV","volume":"5","author":"de-la-lglesia-ln\u0304igo","year":"2017","journal-title":"Clin Case Rep"},{"key":"R102-20250729","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2009.03.009","article-title":"Hematologic characterization and chromosomal localization of the novel dominantly inherited mouse hemolytic anemia, neonatal anemia (Nan)","volume":"43","author":"White","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"R103-20250729","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygeno.2010.07.009","article-title":"Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model","volume":"96","author":"Heruth","year":"2010","journal-title":"Genomics"},{"key":"R104-20250729","doi-asserted-by":"crossref","first-page":"15151","DOI":"10.1073\/pnas.1004996107","article-title":"Severe anemia in the Nan mutant mouse caused by sequence-selective disruption of erythroid Kr\u00fcppel-like factor","volume":"107","author":"Siatecka","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R105-20250729","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3324\/haematol.2019.239830","article-title":"Hemoglobin switching in mice carrying the Klf1 (Nan) variant","volume":"106","author":"Korporaal","year":"2021","journal-title":"Haematologica"},{"key":"R106-20250729","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12864-019-5805-z","article-title":"Corrupted DNA-binding specificity and ectopic transcription underpin dominant neomorphic mutations in KLF\/SP transcription factors","volume":"20","author":"Ilsley","year":"2019","journal-title":"BMC Genomics"},{"key":"R107-20250729","doi-asserted-by":"crossref","first-page":"e00444","DOI":"10.1128\/MCB.00444-19","article-title":"A Kr\u00fcppel-like factor 1 (KLF1) mutation associated with severe congenital dyserythropoietic anemia alters its DNA-binding specificity","volume":"40","author":"Kulczynska","year":"2020","journal-title":"Mol Cell Biol"},{"key":"R108-20250729","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3324\/haematol.2018.209858","article-title":"Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient","volume":"104","author":"Varricchio","year":"2019","journal-title":"Haematologica"},{"key":"R109-20250729","doi-asserted-by":"crossref","first-page":"25.e8\u201337.e8","DOI":"10.1016\/j.exphem.2019.03.001","article-title":"KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells","volume":"73","author":"Kohara","year":"2019","journal-title":"Exp Hemat"},{"key":"R110-20250729","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3324\/haematol.2011.043265","article-title":"Erythroid phenotypes associated with KLF1 mutations","volume":"96","author":"Joseph","year":"2011","journal-title":"Haematologica"},{"key":"R111-20250729","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/MOH.0b013e328358f92e","article-title":"Blood group phenotypes resulting from mutations in erythroid transcription factors","volume":"19","author":"Singleton","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"R112-20250729","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/humu.22218","article-title":"Molecular analysis of the rare In (Lu) blood type: toward decoding the phenotypic outcome of haploinsufficiency for the transcription factor KLF1","volume":"34","author":"Helias","year":"2013","journal-title":"Hum Mutat"},{"key":"R113-20250729","first-page":"221","article-title":"Three fingers on the switch: Kr\u00fcppel-like factor 1 regulation of: (-globin: to: (-globin: gene switching","volume":"34","author":"Tallack","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"(Suppl 1)","key":"R114-20250729","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/ijlh.12356","article-title":"Kr\u00fcppel-like factor 1: hematologic phenotypes associated with KLF1 gene mutations","volume":"37","author":"Waye","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"R115-20250729","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1097\/MPH.0000000000001727","article-title":"A very rare congenital dyserythropoietic anemia variant-type IV in a patient with a novel mutation in the KLF1 gene: a case report and review of the literature","volume":"42","author":"Belgemen-Ozer","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R116-20250729","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12185-010-0688-4","article-title":"Hereditary sideroblastic anemia: pathophysiology and gene mutations","volume":"92","author":"Harigae","year":"2010","journal-title":"Int J Hematol"},{"key":"R117-20250729","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcmd.2013.02.006","article-title":"Erythroid transcription factor EKLF\/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm","volume":"51","author":"Jaffray","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"R118-20250729","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/73480","article-title":"Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1","volume":"24","author":"Nichols","year":"2000","journal-title":"Nat Genet"},{"key":"R119-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2008.09.018","article-title":"Human phenotypes associated with GATA-1 mutations","volume":"427","author":"Ciovacco","year":"2008","journal-title":"Gene"},{"key":"R120-20250729","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI78619","article-title":"X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation","volume":"125","author":"Sankaran","year":"2015","journal-title":"J Clin Invest"},{"key":"R121-20250729","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ajh.25058","article-title":"Multigene panel testing improves diagnosis and management of patients with hereditary anemias","volume":"93","author":"Russo","year":"2018","journal-title":"Am J Hematol"},{"key":"R122-20250729","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/hmg\/ddv057","article-title":"Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors","volume":"24","author":"Ng","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R123-20250729","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/brain\/aww300","article-title":"CAD mutations and uridine-responsive epileptic encephalopathy","volume":"140","author":"Koch","year":"2017","journal-title":"Brain"},{"key":"R124-20250729","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ajh.25946","article-title":"Uridine treatment normalizes the congenital dyserythropoietic anemia type ll-like hematological phenotype in a patient with homozygous mutation in the CAD gene","volume":"95","author":"Russo","year":"2020","journal-title":"Am J Hematol"},{"key":"R125-20250729","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ajhg.2009.02.006","article-title":"Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene","volume":"84","author":"Shteyer","year":"2009","journal-title":"Am J Hum Genet"},{"key":"R126-20250729","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/jmg.2005.030759","article-title":"Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome)","volume":"42","author":"Ferguson","year":"2005","journal-title":"J Med Genet"},{"key":"R127-20250729","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/biom11030367","article-title":"Majeed syndrome: a review of the clinical, genetic and immunologic features","volume":"11","author":"Ferguson","year":"2021","journal-title":"Biomolecules"},{"key":"R128-20250729","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/annrheumdis-2012-201818","article-title":"Efficacy of anti-IL-1 treatment in Majeed syndrome","volume":"72","author":"Herlin","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R129-20250729","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1542\/peds.2009-1774","article-title":"A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia","volume":"125","author":"Samkari","year":"2010","journal-title":"Pediatrics"},{"key":"R130-20250729","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ajhg.2020.10.012","article-title":"De Novo VPS4A mutations cause multisystem disease with abnormal neurodevelopment","volume":"107","author":"Rodger","year":"2020","journal-title":"Am J Hum Genet"},{"key":"R131-20250729","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ajhg.2020.10.013","article-title":"VPS4A mutations in humans cause syndromic congenital dyserythropoietic anemia due to cytokinesis and trafficking defects","volume":"107","author":"Seu","year":"2020","journal-title":"Am J Hum Genet"},{"key":"R132-20250729","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1002\/ajh.26099","article-title":"VPS4A mutation in syndromic congenital hemolytic anemia without obvious signs of dyserythropoiesis","volume":"96","author":"Lunati","year":"2021","journal-title":"Am J Hematol"},{"key":"R133-20250729","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbamcr.2011.08.017","article-title":"Structure and function of the membrane deformation AAA ATPase Vps4","volume":"1823","author":"Hill","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R134-20250729","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1091\/mbc.11.1.227","article-title":"ATPase-defective mammalian VPS4 localizes to aberrant endosomes and impairs cholesterol trafficking","volume":"11","author":"Bishop","year":"2000","journal-title":"Mol Biol Cell"},{"key":"R135-20250729","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ajh.26192","article-title":"Recent advances in the pathophysiology of PIEZO1-related hereditary xerocytosis","volume":"96","author":"Jankovsky","year":"2021","journal-title":"Am J Hematol"},{"key":"R136-20250729","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood.2021011488","article-title":"Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither","volume":"138","author":"Jones","year":"2021","journal-title":"Blood"},{"key":"R137-20250729","doi-asserted-by":"crossref","first-page":"32.e6\u201338.e6","DOI":"10.1016\/j.exphem.2020.09.201","article-title":"Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation","volume":"91","author":"Murphy","year":"2020","journal-title":"Exp Hematol"},{"key":"R138-20250729","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fphys.2019.00621","article-title":"Characterization of two cases of congenital dyserythropoietic anemia type i shed light on the uncharacterized C15orf41 protein","volume":"10","author":"Russo","year":"2019","journal-title":"Front Physiol"}],"container-title":["Current Opinion in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOH.0000000000000697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T21:22:07Z","timestamp":1753824127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOH.0000000000000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":138,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/moh.0000000000000697","relation":{},"ISSN":["1065-6251","1531-7048"],"issn-type":[{"value":"1065-6251","type":"print"},{"value":"1531-7048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,24]]}}}